(Yoshihama et al., 2017; Tang et al., 2020) Furthermore, LCP2 was overexpressed in lung adenocarcinoma, diffuse large B-cell lymphoma, and melanoma, and it was associated with poor prognosis. This evidence concerns the gene LCP2 and diffuse large B-cell lymphoma.